Literature DB >> 12566957

Geographic and temporal distribution of mortality rates for multiple sclerosis in Canada, 1965-1994.

Sharon Warren1, K G Warren, Lawrence W Svenson, Donald P Schopflocher, Allyson Jones.   

Abstract

Statistics Canada data were used to calculate multiple sclerosis (MS) mortality rates per 100,000 population in the Canadian provinces from 1965 to 1994. For the period 1965-1994, the highest average annual MS mortality rates were in Quebec (4.4) and Ontario (3.9), while the Western Provinces had an intermediate rate (2.1) and the Atlantic Provinces had the lowest rate (1.2). Female mortality rates exceeded male rates in each of the four regions. Average annual MS mortality rates in Canada overall fluctuated during the past 30 years, with rates of 3.4 in 1965-1969, 4.2 in 1970-1974, 3.2 in 1975-1979, 2.3 in 1980-1984, 2.8 in 1985-1989 and 3.9 in 1990-1994. Female mortality rates exceeded male rates during each 5-year period. The highest mortality rates for both genders were in the 65 years plus age group. Rates in the under 45 years age group have remained stable, while rates in both the 45-64 and 65 years plus age groups have fluctuated. There is no apparent relationship between prevalence and mortality rates among the Canadian provinces. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12566957     DOI: 10.1159/000067111

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  3 in total

1.  Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.

Authors:  Michael J Goldacre; Marie Duncan; Myfanwy Griffith; Martin R Turner
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

2.  The role of exercise in modifying outcomes for people with multiple sclerosis: a randomized trial.

Authors:  Nancy E Mayo; Mark Bayley; Pierre Duquette; Yves Lapierre; Ross Anderson; Susan Bartlett
Journal:  BMC Neurol       Date:  2013-06-28       Impact factor: 2.474

3.  The rise of mortality from mental and neurological diseases in Europe, 1979-2009: observational study.

Authors:  Johan P Mackenbach; Marina Karanikolos; Caspar W N Looman
Journal:  BMC Public Health       Date:  2014-08-13       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.